期刊文献+

Diagnostic value of HPV and P16 protein in patients with HSIL and prognosis

下载PDF
导出
摘要 Objective: To investigate the diagnostic value and prognostic value of HPV and P16 protein in patients with HSIL and to provide a reference for the clinical diagnosis and assessment of the prognosis of patients with HSIL. Methods: The surgical treatment of HSIL patients from January 2013 to January 2015 in our hospital were selected. All patients were routinely tested for HPV and P16 protein, All patients were followed up for 1 year. Patients were divided into progressive group and quiescent group according to whether the disease progressed one year after surgery. Preoperative HPV and P16 protein levels were compared between the two groups. Using receiver operating curve (ROC curve) Analysis of HPV diagnostic value of HSIL. The levels of HPV and P16 protein in the two groups were analyzed and compared. Results: The quantitative level of high-risk HPV-DNA after LEEP was significantly lower than that before operation. The level of P16 protein in preoperative patients was higher than that before operation, and the difference was statistically significant. There were 21 patients in the postoperative progression group, and the average HPV-DNA content in the patients in the progression group was higher than that in the control group within one year after operation. The difference was statistically significant. The P16 protein level in patients in advanced group was significantly higher than that in resting group. Preoperative HPV-DNA levels and P16 protein levels in patients with progressive disease were significantly higher than those in still group. ROC curve analysis showed that the cut-off value of 2.441, HPV-DNA prediction of HSIL patients one year after the recurrence of the sensitivity was 95.12%, the specificity was 76.16%, under the curve area of 0.878;7.4 cut-off value, P16 The predictive value of HSIL patients recurrence after 1 year was 71.95%, specificity was 66.67%, and the area under the curve was 0.753. The recurrence group HPV-DNA content and P16 protein level showed a significant positive correlation, with statistical significance. Conclusions: LEEP can reduce the postoperative levels of HPV and P16 protein in patients with HSIL. The HPV and P16 protein levels are of high value for the early diagnosis of HSIL and the prediction of postoperative disease progression.
出处 《Journal of Hainan Medical University》 2019年第10期53-56,共4页 海南医学院学报(英文版)
基金 Hainan Natural Science Foundation Surface Project(20168279).
  • 相关文献

参考文献2

二级参考文献19

  • 1Tozawaono A,Yoshida A,Yokomachi N,et al.Heat shock protein 27and p16immunohistochemistry in cervical intraepithelial neoplasia and squamous cell carcinoma[J].Hum Cell,2012,25(1):24-28.
  • 2Gatta L B,Berenzi A,Balzarini P,et al.Diagnostic implications of L1,p16and Ki-67proteins and HPV DNA in low-grade cervical intraepithelial neoplasia[J].Int J Gynecol Pathol,2011,30(6):597-604.
  • 3Ortoft G,Henriksen T,Hansen E,etal.After conisation of the cervic,the perinatal mortality as a result of preterm delivery increases in subsequent pregnancy[J].BJOG,2010,117:258-267.
  • 4Akobsson M,Gissler M,Tiitinen A,et al.Treatment for cervical intraepithelial neoplasia and subsequent IVF deliveries[J].HUM report,2008,23:2252-2255.
  • 5Jin G,Lanlan Z,Li C,et al.Pregnancy outcome following loop electrosurgical excision procedure(LEEP)a systematic review and meta-analysis[J].Arch Gynecol Obstet,2014,289(1):85-99.
  • 6Izadi-Mood N,Sarmadi S,Eftekhar Z,et al.Immunohistochemical expression of p16and HPV L1capsid proteins as predictive markers in cervical lesions[J].ArchGynecol Obstet,2014,289(6):1287-1292.
  • 7Ladstein RG,Bachmann IM,Straume O,et al.Ki-67expression is superior to mitotic count and novel proliferation markers PHH3,MCM4and mitosin as a prognostic factor in thick cutaneous melanoma[J].BMC Cancer,2010,10:140.
  • 8Liao G D,Sellors J W,Sun H K,et al. p16INK4A immunohistochemi- cal staining and predictive value for progression of cervical intraepithe- lial neoplasia grade 1 : A prospective study in China[ J]. Int J Cancer, 2014,134(7) :1715 - 1724.
  • 9Kalof A N, Cooper K. pl6INK4a immunoexpression:surrogate marker of high- risk HPV and high -grade cervical intraepithelial neoplasi [ J ]. Adv Anat Pathol,2006,13(4) :190 -194.
  • 10Cardoso F A, Campaner A B, Silva M A. Prognostic value of pl6lNK4a as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 ( CIN 3) treated by cervical conization[ J]. APMIS, 2014,122(3) :192 - 199.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部